Decreased basal cyclic adenosine 3′,5′-monophosphate levels in Morris hepatoma 5123 t.c.(h)
- 10 July 1974
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 59 (1), 167-173
- https://doi.org/10.1016/s0006-291x(74)80189-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- In vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMPScience, 1974
- Cyclic GMP and Cell MovementNature, 1973
- Cyclic AMP levels and the morphological differentiation of mouse neuroblastoma cellsLife Sciences, 1973
- Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate: concentrations in Morris hepatomas of different growth ratesBiochimica et Biophysica Acta (BBA) - General Subjects, 1973
- Supression of normal and enhanced tumour growth in rats by agents interfering with intracellular cyclic nucleotidesLife Sciences, 1972
- Difference in the Cyclic Adenosine 3′,5′-Monophosphate Levels in Normal and Transformed CellsNature New Biology, 1972
- Protein kinase: Altered regulation in a hepatoma cell line deficient in adenosine 3′, 5′-cyclic monophosphate-binding proteinBiochemical and Biophysical Research Communications, 1972
- Studies on plasma membranes XIV. Adenyl cyclase in plasma membranes isolated from rat and mouse livers and hepatomas, and its hormone sensitivityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971
- Cyclic AMP levels in fibroblasts: Relationship to growth rate and contact inhibition of growthBiochemical and Biophysical Research Communications, 1971
- Inhibition of Tumor Growth by Nucleoside Cyclic 3′,5′-MonophosphatesHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1969